We are live on
!
Find out more
ANI Pharmaceuticals
ANIP
ANIP
28 hedge funds and large institutions have $10.6M invested in ANI Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
903% more call options, than puts
Call options by funds: $4.47M | Put options by funds: $446K
119% more capital invested
Capital invested by funds: $4.84M → $10.6M (+$5.75M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
18% less funds holding
Funds holding: 34 → 28 (-6)
20% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 10
36% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 14
Holders
28
Holders Change
-6
Holders Change %
-17.65%
% of All Funds
0.91%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
8
Reduced
10
Closed
14
Calls
$4.47M
Puts
$446K
Net Calls
+$4.03M
Net Calls Change
+$3.59M
Top Buyers
Top Sellers
| 1 |
Nomura Holdings
Tokyo,
Japan
|
-$59K |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$38K |
| 3 |
Renaissance Technologies
New York
|
-$36K |
| 4 |
Goldman Sachs
New York
|
-$33K |
| 5 |
D.E. Shaw & Co
New York
|
-$24K |
